Scientists Confirm the First-Ever Human Cancer Caused by Tapeworm Cells Not Human DNA

For the first time, scientists have confirmed tapeworm cancer in humans, where malignant cells originated from a parasite rather than human DNA. In a rare and fatal case involving Hymenolepis nana, researchers uncovered how tapeworm cells evolved into aggressive tumors inside an immunocompromised patient challenging long-held definitions of cancer.

Developing cancer that is not derived from your own cells. Instead, the malignant cells belong to a parasite living inside you. In 2013, physicians in Colombia encountered precisely this scenario a medical anomaly that would later redefine how scientists think about cancer and infectious disease.

A common intestinal parasite, the dwarf tapeworm Hymenolepis nana, did more than infect its human host. It underwent malignant transformation, producing aggressive, cancer-like cells that spread throughout the patient’s body. Documented in a landmark New England Journal of Medicine study, this case represents the first confirmed instance of parasite-derived cancer in a human, fundamentally blurring the boundary between infection and oncology.

Tiny Parasite With an Outsized Impact

Tapeworm infections are far from rare. Hymenolepis nana is the most common human tapeworm globally, infecting an estimated up to 75 million people, particularly in regions with inadequate sanitation. Adult worms measure only 1–4 cm in length, yet their biology is unusually efficient.

Unlike most tapeworms, H. nana can complete its entire life cycle within a single host. Eggs hatch directly in the intestine, larvae penetrate the intestinal wall, and new adult worms emerge without the need for an intermediate animal host. Heavy infections may cause abdominal pain, diarrhea, anemia, or malnutrition especially in children.

In immunocompetent individuals, the immune system typically controls the parasite. In fact, experimental studies suggest some helminths may suppress tumor development. Mouse models have shown that H. nana infection can reduce skin tumors induced by the carcinogen 7,12-dimethylbenz[a]anthracene (DMBA), likely through increased activity of eosinophils and neutrophils.

Reviews of parasite cancer interactions echo this paradox: while helminths may modulate immunity in ways that inhibit tumors, the mechanisms remain poorly understood.

In this human case, however, the relationship inverted the parasite itself became malignant.

From Infection to Fatal Diagnosis

The patient was a 41-year-old man from Medellín, Colombia, who presented in January 2013 with months of fatigue, fever, cough, and severe weight loss. He had been diagnosed with HIV in 2006 but had not adhered to antiretroviral therapy. His immune system was profoundly compromised, with a CD4 count of just 28 cells/mm³ (normal range: 500–1,500).

Stool examinations revealed H. nana eggs along with Blastocystis hominis. Imaging studies uncovered widespread disease: nodules in the lungs (up to 4.4 cm), liver, and adrenal glands, along with extensive lymphadenopathy in the neck, chest, and abdomen.

Physicians initially suspected an aggressive human cancer, such as lymphoma or metastatic lung carcinoma. Biopsies from cervical lymph nodes and lung tissue showed densely packed, highly proliferative cells with mitotic activity, necrosis, vascular invasion, and occasional multinucleated syncytia.

Yet these cells were unusually small only 5–6 micrometers in diameter, roughly one-tenth the size of typical human cancer cells. They lacked human epithelial and mesenchymal markers, including cytokeratin and vimentin, raising serious doubts about their origin.

Despite treatment with albendazole and reinitiation of antiretroviral therapy, the disease progressed rapidly. A second biopsy confirmed expanding nodular masses. The patient developed renal failure and died in May 2013, only days after the final diagnosis. No autopsy was performed.

Solving the Mystery: Cancer Cells That Were Not Human

Tissue samples were sent to the U.S. Centers for Disease Control and Prevention (CDC), where advanced molecular analyses unraveled the mystery.

Broad-range PCR targeting eukaryotic DNA identified sequences belonging to Hymenolepis nana. Immunohistochemistry using antibodies against tapeworm antigens strongly stained the tumor cells, while probes specific for human DNA did not bind.

In situ hybridization confirmed the presence of H. nana RNA within the malignant tissue. Electron microscopy revealed undifferentiated cells rich in ribosomes and mitochondria, lacking differentiated tapeworm structures such as hooks or suckers features consistent with proliferating stem-like cells.

Genomic sequencing provided definitive evidence. The tumor cells carried hallmark cancer mutations, including:

Large gene amplifications (13–25×) in regions such as LAMP2
Structural rearrangements and insertions disrupting PHF10 (chromatin remodeling) and ULK2 (autophagy regulation)
Mitochondrial DNA alterations associated with metabolic dysfunction

These findings indicated that H. nana stem cells (neoblasts) had proliferated uncontrollably, accumulated oncogenic mutations, and invaded human tissues effectively behaving as a transmissible parasite cancer within an immunocompromised host.

As the authors concluded, this case reveals:

“Invasion of human tissue by abnormal, proliferating, genetically altered tapeworm cells is a novel disease mechanism that links infection and cancer.”

Although extraordinarily rare, this phenomenon has significant implications for regions where HIV and H. nana infections overlap, including parts of Africa, Asia, and Latin America. Similar cases could be misdiagnosed as conventional human cancers, leading to ineffective treatment.

Standard chemotherapy may not target parasite-derived cells, while antiparasitic drugs may fail once clonal malignancy is established. Conversely, understanding how parasites modulate immunity sometimes suppressing tumors, other times becoming malignant could open unexpected therapeutic avenues.

For now, the case reinforces basic public health priorities: sanitation, clean water, parasite control, and consistent HIV treatment.

Published in 2015, this discovery reminds us that cancer is not always a purely human disease and that evolution can turn even the smallest parasite into a deadly adversary.